LKB1/AMPK treats myocardial disease by boosting mitochondrial function

Int J Cardiol. 2024 Mar 1:398:131645. doi: 10.1016/j.ijcard.2023.131645. Epub 2023 Dec 6.

Authors

Zhihuan Luo¹, Luyuan Yao²

Affiliations

¹ Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, China.
² Department of Anesthesiology, Taihe Hospital, Hubei University of Medicine, Anesthesiology Research Institute of Hubei University of Medicine, Shiyan, Hubei Province, China. Electronic address: ana4718369@163.com.

PMID: 38065324
DOI: 10.1016/j.ijcard.2023.131645

No abstract available

Keywords: AMPK; Cardiomyopathy; LKB1; Mitochondrial dysfunction.

Publication types

Letter

MeSH terms

AMP-Activated Protein Kinases* / metabolism
Cardiomyopathies* / metabolism
Humans
Mitochondria / metabolism
Phosphorylation
Protein Serine-Threonine Kinases / metabolism
Signal Transduction

Substances

AMP-Activated Protein Kinases
Protein Serine-Threonine Kinases